Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-17

Clinical Trial Update: The Effect of Diflunisal on Familial Amyloidosis [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion and results posting of phase 2 and phase 3 trials evaluating diflunisal for familial amyloid polyneuropathy and familial amyl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIFLUNISAL (Diflunisal)

Snippet

Sponsor: Boston University | Conditions: Familial Amyloid Polyneuropathy, Familial Amyloidosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-03-17